These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31778222)

  • 1. Impact of Intensive Blood Pressure Therapy on Concern about Falling: Longitudinal Results from the Systolic Blood Pressure Intervention Trial (SPRINT).
    Berlowitz DR; Foy C; Conroy M; Evans GW; Olney CM; Pisoni R; Powell JR; Gure TR; Shorr RI
    J Am Geriatr Soc; 2020 Mar; 68(3):614-618. PubMed ID: 31778222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension Treatment and Concern About Falling: Baseline Data from the Systolic Blood Pressure Intervention Trial.
    Berlowitz DR; Breaux-Shropshire T; Foy CG; Gren LH; Kazis L; Lerner AJ; Newman JC; Powell JR; Riley WT; Rosman R; Wadley VG; Williams JA;
    J Am Geriatr Soc; 2016 Nov; 64(11):2302-2306. PubMed ID: 27640987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
    PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
    Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.
    Egan BM; Li J; Wagner CS
    Hypertension; 2016 Aug; 68(2):318-23. PubMed ID: 27354422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial.
    Margolis KL; Palermo L; Vittinghoff E; Evans GW; Atkinson HH; Hamilton BP; Josse RG; O'Connor PJ; Simmons DL; Tiktin M; Schwartz AV
    J Gen Intern Med; 2014 Dec; 29(12):1599-606. PubMed ID: 25127725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial.
    Nasrallah IM; Gaussoin SA; Pomponio R; Dolui S; Erus G; Wright CB; Launer LJ; Detre JA; Wolk DA; Davatzikos C; Williamson JD; Pajewski NM; Bryan RN;
    JAMA Neurol; 2021 May; 78(5):568-577. PubMed ID: 33683313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Intensive vs Standard Blood Pressure Treatment Upon Erectile Function in Hypertensive Men: Findings From the Systolic Blood Pressure Intervention Trial.
    Foy CG; Newman JC; Russell GB; Berlowitz DR; Bates JT; Burgner AM; Carson TY; Chertow GM; Doumas MN; Hughes RY; Kostis JB; Buren PV; Wadley VG;
    J Sex Med; 2020 Feb; 17(2):238-248. PubMed ID: 31862174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
    JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension Treatment and Control and Risk of Falls in Older Women.
    Margolis KL; Buchner DM; LaMonte MJ; Zhang Y; Di C; Rillamas-Sun E; Hunt J; Ikramuddin F; Li W; Marshall S; Rosenberg D; Stefanick ML; Wallace R; LaCroix AZ
    J Am Geriatr Soc; 2019 Apr; 67(4):726-733. PubMed ID: 30614525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Wang KM; Stedman MR; Chertow GM; Chang TI
    Hypertension; 2020 Dec; 76(6):1725-1733. PubMed ID: 33131314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity.
    Hajjar I; Rosenberger KJ; Kulshreshtha A; Ayonayon HN; Yaffe K; Goldstein FC
    JAMA Neurol; 2017 Oct; 74(10):1199-1205. PubMed ID: 28828478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial.
    Sink KM; Evans GW; Shorr RI; Bates JT; Berlowitz D; Conroy MB; Felton DM; Gure T; Johnson KC; Kitzman D; Lyles MF; Servilla K; Supiano MA; Whittle J; Wiggers A; Fine LJ
    J Am Geriatr Soc; 2018 Apr; 66(4):679-686. PubMed ID: 29601076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
    Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial.
    Odden MC; Peralta CA; Berlowitz DR; Johnson KC; Whittle J; Kitzman DW; Beddhu S; Nord JW; Papademetriou V; Williamson JD; Pajewski NM;
    JAMA Intern Med; 2017 Apr; 177(4):500-507. PubMed ID: 28166324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial.
    Attar A; Sayadi M; Jannati M
    Eur J Prev Cardiol; 2019 Feb; 26(3):238-245. PubMed ID: 30256671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.